Biohaven Ltd.

XNYSHealth care

Last traded price · USD

$15.30

+0.39%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 18:28 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $15.24
Volume: 46,057
Day's high: —
Day's low: —

In brief

Biohaven Ltd. is a health care company listed on the New York Stock Exchange, valued at about $2.31B.
Its shares closed at $15.24 on 4 Nov 2026, up 9.2% over the past year.
From India you can buy BHVN in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Biohaven Ltd. (BHVN) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole BHVN share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade BHVN options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Above its 50- and 200-day averages
The 4 Nov 2026 close of $15.24 was 11.2% above its 50-day average ($13.71) and 24.2% above its 200-day average ($12.27). It has closed above the 200-day for 10 sessions, since 22 Oct 2026. The 50-day average crossed above the 200-day on 9 Jul 2026, 83 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +26.2% (SPY −1.6%, XLV +13.5%). 3 months: +11.8% (SPY −0.4%, XLV +15.5%). 1 year: +9.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BHVN, SPY and XLV · as of 4 Nov 2026
9.2 days to cover short interest
17.9M shares were sold short at the 15 Oct 2026 settlement, 11.8% of the 151.1M shares outstanding; covering them would take 9.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
72% of the way up its 52-week range
Closed at $15.24 on 4 Nov 2026: 16.4% below the 52-week high of $18.24 (26 Aug 2026) and 103.7% above the low of $7.48 (11 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+26.2%

6 months+51.8%

1 year+9.2%

5 years−89.7%

Newswire

About

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Website

Notable moves

October 5, 2022
+47.59%
October 4, 2022
−94.53%
May 10, 2022
+68.39%

Newswire

About

Website

Notable moves

October 5, 2022
+47.59%
October 4, 2022
−94.53%
May 10, 2022
+68.39%

Biohaven Ltd.

XNYSHealth care

Last traded price · USD

$15.30

+0.39%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 18:28 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $15.24
Volume: 46,057
Day's high: —
Day's low: —

In brief

Biohaven Ltd. is a health care company listed on the New York Stock Exchange, valued at about $2.31B.
Its shares closed at $15.24 on 4 Nov 2026, up 9.2% over the past year.
From India you can buy BHVN in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Biohaven Ltd. (BHVN) shares from India?

Do I need the price of a whole BHVN share to invest?

How much can I invest in US stocks in a year?

Can I trade BHVN options or futures?

Insights

Quotes run fifteen minutes behind.

Above its 50- and 200-day averages
The 4 Nov 2026 close of $15.24 was 11.2% above its 50-day average ($13.71) and 24.2% above its 200-day average ($12.27). It has closed above the 200-day for 10 sessions, since 22 Oct 2026. The 50-day average crossed above the 200-day on 9 Jul 2026, 83 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +26.2% (SPY −1.6%, XLV +13.5%). 3 months: +11.8% (SPY −0.4%, XLV +15.5%). 1 year: +9.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BHVN, SPY and XLV · as of 4 Nov 2026
9.2 days to cover short interest
17.9M shares were sold short at the 15 Oct 2026 settlement, 11.8% of the 151.1M shares outstanding; covering them would take 9.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
72% of the way up its 52-week range
Closed at $15.24 on 4 Nov 2026: 16.4% below the 52-week high of $18.24 (26 Aug 2026) and 103.7% above the low of $7.48 (11 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+26.2%

6 months+51.8%

1 year+9.2%

5 years−89.7%

Newswire

About

Website

Notable moves

October 5, 2022
+47.59%
October 4, 2022
−94.53%
May 10, 2022
+68.39%

Newswire

About

Website

Notable moves

October 5, 2022
+47.59%
October 4, 2022
−94.53%
May 10, 2022
+68.39%

Biohaven Ltd.

Biohaven Ltd. in brief

Above its 50- and 200-day averages

Behind SPY and its sector fund XLV over 1 year

9.2 days to cover short interest

72% of the way up its 52-week range

Biohaven Ltd.

Biohaven Ltd. in brief

Above its 50- and 200-day averages

Behind SPY and its sector fund XLV over 1 year

9.2 days to cover short interest

72% of the way up its 52-week range